Algert Global LLC Syndax Pharmaceuticals Inc Transaction History

Algert Global LLC

$2.55 Billion
Q1 2024

A detailed history of Algert Global LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Algert Global LLC holds 425,673 shares of SNDX stock, worth $8.74 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

425,673

Previous 528,157 19.4%

Holding current value

$8.74 Million

Previous $11.4 Million 11.23%

% of portfolio

0.4%

Previous 0.46%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$19.71 - $24.57 $2.02 Million - $2.52 Million	-102,484 Reduced 19.4%	425,673 $10.1 Million
Q4 2023 Feb 14, 2024	BUY	$11.39 - $21.67 $819,373 - $1.56 Million	71,938 Added 15.77%	528,157 $11.4 Million
Q3 2023 Nov 13, 2023	BUY	$14.52 - $21.77 $2.94 Million - $4.41 Million	202,588 Added 79.88%	456,219 $6.62 Million
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $3.24 Million - $3.74 Million	167,660 Added 195.02%	253,631 $5.31 Million
Q1 2023 May 12, 2023	BUY	$20.66 - $28.98 $169,226 - $237,375	8,191 Added 10.53%	85,971 $1.82 Million

Q4 2022 Feb 13, 2023	BUY	$20.64 - $26.24 $596,083 - $757,811	28,880 Added 59.06%	77,780 $1.98 Million
Q3 2022 Nov 15, 2022	SELL	$18.51 - $24.79 $107,617 - $144,129	-5,814 Reduced 10.63%	48,900 $1.18 Million
Q2 2022 Aug 15, 2022	BUY	$13.64 - $19.48 $179,775 - $256,746	13,180 Added 31.73%	54,714 $1.05 Million
Q1 2022 May 16, 2022	BUY	$14.84 - $22.15 $147,628 - $220,348	9,948 Added 31.49%	41,534 $722,000
Q4 2021 Feb 14, 2022	BUY	$15.23 - $22.47 $481,054 - $709,737	31,586 New	31,586 $691,000
Q2 2021 Aug 13, 2021	SELL	$13.42 - $25.18 $128,161 - $240,469	-9,550 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$19.28 - $24.59 $347,425 - $443,111	-18,020 Reduced 65.36%	9,550 $214,000
Q4 2020 Feb 12, 2021	BUY	$15.1 - $26.44 $127,444 - $223,153	8,440 Added 44.12%	27,570 $613,000
Q3 2020 Nov 16, 2020	BUY	$13.39 - $17.48 $111,806 - $145,958	8,350 Added 77.46%	19,130 $282,000
Q2 2020 Aug 12, 2020	SELL	$8.94 - $20.98 $105,492 - $247,564	-11,800 Reduced 52.26%	10,780 $160,000
Q1 2020 May 13, 2020	SELL	$6.65 - $12.03 $19,950 - $36,090	-3,000 Reduced 11.73%	22,580 $248,000
Q4 2019 Feb 18, 2020	BUY	$5.43 - $9.22 $44,037 - $74,774	8,110 Added 46.42%	25,580 $225,000
Q3 2019 Nov 14, 2019	BUY	$7.47 - $10.76 $11,952 - $17,216	1,600 Added 10.08%	17,470 $131,000
Q2 2019 Aug 14, 2019	BUY	$4.9 - $9.31 $77,763 - $147,749	15,870 New	15,870 $148,000
Q3 2018 Nov 14, 2018	SELL	$6.33 - $8.08 $465,248 - $593,871	-73,499 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$6.93 - $14.63 $509,348 - $1.08 Million	73,499 New	73,499 $516,000

Others Institutions Holding SNDX

# of Institutions

195

Shares Held

90M

Call Options Held

353K

Put Options Held

207K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $1.16B
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Syndax Pharmaceuticals Inc Transaction History